Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 2.732
Filtrar
1.
Pharm Res ; 37(3): 38, 2020 Jan 21.
Artigo em Inglês | MEDLINE | ID: mdl-31965333

RESUMO

PURPOSE: Asthma is a prevalent lung disorder that cause heavy burdens globally. Inhalation medicaments can relieve symptoms, improve lung function and, thus, the quality of life. However, it is well-documented that patients often do not get the prescribed dose out of an inhaler and the deposition of drug is suboptimal, due to incorrect handling of the device and wrong inhalation technique. This study aims to design and fabricate an acoustic dry powder inhaler (ADPI) for monitoring inhalation flow and related drug administration in order to evaluate whether the patient receives the complete dose out of the inhaler. METHODS: The devices were fabricated using 3D printing and the impact of the acoustic element geometry and printing resolution on the acoustic signal was investigated. Commercial Foradil (formoterol fumarate) capsules were used to validate the availability of the ADPI for medication dose tracking. The acoustic signal was analysed with Partial-Least-Squares (PLS) regression. RESULTS: Indicate that specific acoustic signals could be generated at different air flow rates using a passive acoustic element with specific design features. This acoustic signal could be correlated with the PLS model to the air flow rate. A more distinct sound spectra could be acquired at higher printing resolution. The sound spectra from the ADPI with no capsule, a full capsule and an empty capsule are different which could be used for medication tracking. CONCLUSIONS: This study shows that it is possible to evaluate the medication quality of inhaled medicaments by monitoring the acoustic signal generated during the inhalation process.


Assuntos
Asma/tratamento farmacológico , Broncodilatadores/química , Inaladores de Pó Seco/instrumentação , Fumarato de Formoterol/química , Impressão Tridimensional , Acústica , Administração por Inalação , Asma/fisiopatologia , Broncodilatadores/administração & dosagem , Sistemas de Liberação de Medicamentos/instrumentação , Desenho de Equipamento/instrumentação , Fumarato de Formoterol/administração & dosagem , Humanos , Análise dos Mínimos Quadrados , Pulmão/metabolismo , Monitorização Fisiológica/instrumentação , Pós/química , Pós/farmacologia , Análise de Regressão , Som
2.
J Agric Food Chem ; 68(6): 1536-1545, 2020 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-31961689

RESUMO

In this work, an electrical-driven release and migration glyphosate (EDRMG) was fabricated using a nanocomposite made up of attapulgite (ATP), glyphosate (Gly), and calcium alginate (CA). Therein, ATP-CA acted as a nanonetwork-structured carrier to efficiently load plenty of Gly to form porous ATP-Gly-CA hydrogel spheres (actually EDRMG-0.5) via a cross-linking reaction. The pores in EDRMG-0.5 hydrogel spheres were enlarged under an electric field because of the Coulomb force of the anionic CA polymer, and the release of negatively charged Gly from the spheres could be driven by the electric field force. Thus, EDRMG-0.5 exhibited a great electroresponsively controlled-release property, which was confirmed by a pot experiment. Importantly, the EDRMG-0.5 hydrogel spheres had fine biocompatibility on fish and mice, displaying good biosafety. This work provides a low cost and promising approach to control Gly release, deliver Gly precisely, and improve utilization efficiency, which might have a high application value.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Glicina/análogos & derivados , Herbicidas/química , /química , Alginatos/química , Animais , Portadores de Fármacos/química , Composição de Medicamentos , Sistemas de Liberação de Medicamentos/economia , Sistemas de Liberação de Medicamentos/instrumentação , Eletricidade , Peixes , Glicina/química , Hidrogéis/química , Compostos de Magnésio/química , Camundongos , Compostos de Silício/química
3.
World Neurosurg ; 135: e548-e561, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31866457

RESUMO

BACKGROUND: Placement of Ommaya reservoirs for the administration of intrathecal chemotherapy may be complicated by comorbid thrombocytopenia among patients with hematologic or leptomeningeal disease. Aggregated data on risks of Ommaya placement among thrombocytopenic patients are lacking. This study assesses complications, revision rates, and costs associated with Ommaya placement among patients with thrombocytopenia in a large population sample. METHODS: Using a national administrative database, this retrospective study identifies a cohort of adult patients with cancer who underwent Ommaya placement between 2007 and 2016. Preoperative thrombocytopenia was defined as diagnosis of secondary thrombocytopenia, bleeding event, procedure to control bleeding, or platelet transfusion, within 30 days before index admission. Univariate and multivariate analyses were performed to assess costs, 30-day complications, readmissions, and revisions among patients with and without preoperative thrombocytopenia. RESULTS: The analytic cohort included 1652 patients, of whom 29.3% met criteria for preoperative thrombocytopenia. In-hospital mortality rates were 7.7% among patients thrombocytopenia with versus 1.2% among patients without thrombocytopenia (P < 0.001). Preoperative thrombocytopenia was associated with 14.5 times greater hazard of intracranial hemorrhage within 30 days following Ommaya placement, occurring in 25.6% versus 2.0% of patients with and without thrombocytopenia, respectively (P < 0.014). Revision rates did not differ significantly between patients with and without thrombocytopenia. Thrombocytopenia was associated with longer length of stay (7.4 vs. 13.9 days, P < 0.001) and additional $10,000 per patient in costs of index hospitalization (P < 0.001). CONCLUSIONS: This is the largest study to date documenting costs and complication rates of Ommaya placement in patients with and without thrombocytopenia.


Assuntos
Neoplasias/tratamento farmacológico , Trombocitopenia/complicações , Idoso , Antineoplásicos/administração & dosagem , Antineoplásicos/economia , Cateteres de Demora/economia , Custos e Análise de Custo , Sistemas de Liberação de Medicamentos/economia , Sistemas de Liberação de Medicamentos/instrumentação , Feminino , Humanos , Cobertura do Seguro , Seguro Saúde , Masculino , Neoplasias/economia , Estudos Retrospectivos , Trombocitopenia/economia , Resultado do Tratamento , Estados Unidos
4.
Pharm Res ; 36(12): 183, 2019 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-31741058

RESUMO

Research conducted in microgravity conditions has the potential to yield new therapeutics, as advances can be achieved in the absence of phenomena such as sedimentation, hydrostatic pressure and thermally-induced convection. The outcomes of such studies can significantly contribute to many scientific and technological fields, including drug discovery. This article reviews the existing traditional microgravity platforms as well as emerging ideas for enabling microgravity research focusing on SpacePharma's innovative autonomous remote-controlled microgravity labs that can be launched to space aboard nanosatellites to perform drug research in orbit. The scientific literature is reviewed and examples of life science fields that have benefited from studies in microgravity conditions are given. These include the use of microgravity environment for chemical applications (protein crystallization, drug polymorphism, self-assembly of biomolecules), pharmaceutical studies (microencapsulation, drug delivery systems, behavior and stability of colloidal formulations, antibiotic drug resistance), and biological research, including accelerated models for aging, investigation of bacterial virulence , tissue engineering using organ-on-chips in space, enhanced stem cells proliferation and differentiation.


Assuntos
Simulação de Ausência de Peso/instrumentação , Simulação de Ausência de Peso/métodos , Ausência de Peso , Fatores Etários , Diferenciação Celular , Linhagem Celular , Proliferação de Células , Cristalização/instrumentação , Cristalização/métodos , Dimerização , Composição de Medicamentos/instrumentação , Composição de Medicamentos/métodos , Sistemas de Liberação de Medicamentos/instrumentação , Sistemas de Liberação de Medicamentos/métodos , Descoberta de Drogas/instrumentação , Descoberta de Drogas/métodos , Resistência Microbiana a Medicamentos , Humanos , Microfluídica/instrumentação , Microfluídica/métodos , Pesquisa Farmacêutica/instrumentação , Pesquisa Farmacêutica/métodos , Fenômenos Físicos , Proteínas/química , Voo Espacial , Engenharia Tecidual/instrumentação , Engenharia Tecidual/métodos
5.
J Agric Food Chem ; 67(39): 10904-10912, 2019 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-31508953

RESUMO

High-order multiple emulsions are of great interest in both fundamental research and industrial applications as vehicles for their encapsulation capability of actives. In this work, we report a hierarchically multicompartmental highly stable triple emulsion by emulsifying and assembling of natural Quillaja saponin. Water-in-oil-in-(oil-in-water) (W2/O2/(O1/W1)) triple emulsion indicates that the compartmented system consisted of surfaced saponin-coated nanodroplets (SNDs) and dispersed oil globules, which in turn contained smaller aqueous droplets. The effects of formulation parameters, including lipophilic emulsifier content, oil fraction, and SND concentration, on the formation of multiple emulsions were systematically investigated. The assembly into fibrillar network of SNDs at the outer oil-water interface effectively protected the triple emulsion droplets against flocculation and coalescence, and strongly prevented the osmotic-driven water diffusion between the internal water droplets and the external water phase, thus contributing to superior stability during 180 days storage. All of these characteristics make the multicompartmentalized emulsions suitable to co-encapsulate a hydrophilic bioactive (gardenia blue) and two hydrophobic bioactives (eapsanthin and curcumin) in a single emulsion droplet hierarchically for the segregation and protection of multiple cargos. This approach offers a promising route toward accessing the next generation of functional deliveries and encapsulation strategies.


Assuntos
Curcumina/química , Sistemas de Liberação de Medicamentos/métodos , Extratos Vegetais/química , Quillaja/química , Saponinas/química , Composição de Medicamentos , Sistemas de Liberação de Medicamentos/instrumentação , Emulsificantes/química , Emulsões/química , Glucosídeos/química , Óleos/química , Tamanho da Partícula , Água/química
6.
Mater Sci Eng C Mater Biol Appl ; 105: 110070, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31546372

RESUMO

Also known as electrospray, electrohydrodynamic atomization has been used extensively in the last 15 years to develop polymer-based particles for drug delivery in cell and animal models. More recently, novel core-shell, multi-axial, and other electrospray particles have been developed from an array of polymers for a variety of biomedical applications. This review focuses on electrospray as a novel method of particle fabrication for drug delivery, specifically highlighting the applications of these particle systems in cell culture and animal models while also discussing polymers used for particle fabrication. Applications of electrospray particles to treat glioma, ovarian cancer, and breast cancer are reviewed. Additionally, delivery of antibiotics, gene therapy, and bacterial cells formulated in electrospray particles is discussed. Finally, vaccines as well as drug eluting particles for differentiation of stem cells and tissue engineering are highlighted. The article concludes with a discussion of where the future of electrospray technology can go to strengthen its foothold in the biomedical field.


Assuntos
Sistemas de Liberação de Medicamentos/instrumentação , Sistemas de Liberação de Medicamentos/métodos , Vacinas/uso terapêutico , Animais , Preparações de Ação Retardada/uso terapêutico , Humanos , Polímeros/química
7.
J Agric Food Chem ; 67(35): 9719-9726, 2019 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-31398015

RESUMO

Pickering high internal phase emulsions (HIPEs) are normally highly concentrated emulsions stabilized by colloidal particles with a minimum internal phase volume fraction of 0.74. They have received considerable attention in many fields, including pharmaceuticals, tissue engineering, foods, and personal care products. The aim of this perspective is to update the current knowledge on the field of protein-based Pickering HIPEs, emphasizing those aspects that need to be explored and clarified. Research progress in constructing HIPEs by protein-type colloid particles and promising research trends in basic research and potential applications were highlighted. Promising studies in this field include (1) clarifying bioavailability and evolution of activity of active ingredients in Pickering HIPEs by oral administration, (2) constructing a Pickering interfacial catalysis platform using protein colloidal particles, and (3) expanding the emerging applications of Pickering HIPEs in fields, such as partially hydrogenated oil replacers, probiotic encapsulation, and the template for porous materials.


Assuntos
Suplementos Nutricionais/análise , Emulsões/química , Proteínas/química , Coloides/química , Sistemas de Liberação de Medicamentos/instrumentação , Sistemas de Liberação de Medicamentos/métodos , Excipientes/química , Nanopartículas/química , Tamanho da Partícula , Porosidade
8.
J Agric Food Chem ; 67(33): 9371-9381, 2019 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-31379162

RESUMO

A major obstacle to the clinical use of curcumin (CUR) is its reduced bioavailability because of the drug's hydrophobic nature, low intestinal absorption, and rapid metabolism. In this study, a novel oral drug delivery system was constructed for improving the stability and enhancing mucoadhesion of CUR in the gastrointestinal (GI) tract. First, CUR was encapsulated in the bovine serum albumin nanoparticles (CUR-BSA-NPs). Then, N-acetyl cysteine (NAC)-modified CUR-BSA-NPs (CUR-NBSA-NPs) were obtained. The average particle size and zeta potential of CUR-NBSA-NPs were 251.6 nm and -30.66 mV, respectively; encapsulation efficiency and drug loading were 85.79 and 10.9%, respectively. CUR-NBSA-NPs exhibited a sustained release property and prominently enhanced stability in simulated GI conditions. Additionally, enhanced mucoadhesion of CUR-NBSA-NPs was also observed. An MTT study showed that the CUR-NBSA-NPs were safe for oral administration. Overall, NAC-modified BSA-NPs may potentially serve as an oral vehicle for improving CUR stability in the GI tract and enhancing mucoadhesion.


Assuntos
Acetilcisteína/química , Curcumina/química , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos/instrumentação , Trato Gastrointestinal/metabolismo , Nanopartículas/química , Soroalbumina Bovina/química , Animais , Células CACO-2 , Bovinos , Curcumina/metabolismo , Estabilidade de Medicamentos , Humanos , Tamanho da Partícula
9.
Clin Drug Investig ; 39(11): 1021-1030, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31377981

RESUMO

Successful treatment for respiratory diseases relies on effective delivery of medication to the lungs using an inhalation device. Different inhalers have distinct characteristics affecting drug administration and patient adherence, which can impact clinical outcomes. We report on the development of the Respimat® soft mist inhaler (SMI) and compare key attributes with metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). The Respimat SMI, a pocket-sized device generating a single-breath, inhalable aerosol, was designed to enhance drug delivery to the lungs, reduce the requirements for patient coordination and inspiratory effort, and improve the patients' experience and ease of use. The drug deposition profile with Respimat SMI is favorable compared with MDIs and DPIs, with higher drug deposition to the lung and peripheral airways. The slow velocity and long spray duration of the Respimat SMI aerosol also aid patient coordination. Clinical equivalence has been demonstrated for maintenance treatment of chronic obstructive pulmonary disease using once-daily tiotropium between Respimat SMI (5 µg) and HandiHaler DPI (18 µg). In comparative studies, patients preferred Respimat SMI to MDIs and DPIs; they reported that Respimat SMI was easy to use and felt the inhaled dose was delivered. The Respimat SMI, designed to generate a slow-moving and fine mist, is easy to use and effectively delivers drug treatment to the lungs. The patient-centered design of Respimat SMI improved patient satisfaction, and may help to promote long-term adherence and improve clinical outcomes with asthma and chronic obstructive pulmonary disease.


Assuntos
Combinação Albuterol e Ipratrópio/administração & dosagem , Broncodilatadores/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Desenho de Equipamento/métodos , Inaladores Dosimetrados , Administração por Inalação , Combinação Albuterol e Ipratrópio/metabolismo , Asma/tratamento farmacológico , Asma/metabolismo , Broncodilatadores/metabolismo , Sistemas de Liberação de Medicamentos/instrumentação , Humanos , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/metabolismo
10.
Anaesthesia ; 74(11): 1425-1431, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31373391

RESUMO

Syringe infusion pumps are used for the administration of short-acting drugs in anaesthesia and critical care medicine, but are prone to flow irregularities at low flow rates. A flow-controlled syringe infusion pump using an integrated flow sensor for feedback control represents a new approach to overcoming these limitations. This study compares the performance of a prototype flow-controlled syringe pump both at start-up, and during vertical displacement manoeuvres, with that of a standard infusion syringe pump. The novel pump almost completely eliminated delays at start-up and flow irregularities during hydrostatic pressure changes. Related fluctuations in plasma drug concentration were minimised and the known disadvantages of standard syringe infusion pumps currently used in clinical practice were reduced. Besides providing fast start-up to steady-state flow and precise continuous drug delivery at low flow rates during hydrostatic pressure changes, the new pump offers the potential for the development of target-controlled infusion algorithms for short-acting cardiovascular and other drugs.


Assuntos
Anestésicos/administração & dosagem , Sistemas de Liberação de Medicamentos/instrumentação , Desenho de Equipamento , Bombas de Infusão , Infusões Intravenosas/instrumentação , Seringas , Anestesia/métodos , Projetos de Pesquisa , Fatores de Tempo
11.
J Agric Food Chem ; 67(37): 10481-10488, 2019 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-31433940

RESUMO

Here, we report two methods that chemically modify alginate to achieve neutral-basic pH sensitivity of the resultant hydrogel. The first method involves direct amide bond formation between alginate and 4-(2-aminoethyl)benzoic acid. The second method that arose out of the desire to achieve better control of the degradation rate of the alginate hydrogel involves reductive amination of oxidized alginate. The products of both methods result in a hydrogel vehicle for targeted delivery of encapsulated payload under physiological conditions in the gastrointestinal tract. Two-dimensional diffusion-ordered spectroscopy and internal and coaxial external nuclear magnetic resonance standards were used to establish chemical bonding and percent incorporation of the modifying groups into the alginate polymer. The hydrogel made with alginate modified by each method was found to be completely stable under acidic pH conditions while disintegrating within minutes to hours in neutral-basic pH conditions. We found that, while alginate oxidation did not affect the ß-d-mannuronate/α-l-guluronate ratio of alginate, the rate of disintegration of the hydrogel made with oxidized alginate was dependent upon the degree of oxidation.


Assuntos
Alginatos/química , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos/instrumentação , Administração Oral , Difusão , Hidrogéis/química , Concentração de Íons de Hidrogênio , Oxirredução , Polímeros/química
12.
Nat Commun ; 10(1): 3777, 2019 08 22.
Artigo em Inglês | MEDLINE | ID: mdl-31439845

RESUMO

Investigation and modulation of neural circuits in vivo at the cellular level are very important for studying functional connectivity in a brain. Recently, neural probes with stimulation capabilities have been introduced, and they provided an opportunity for studying neural activities at a specific region in the brain using various stimuli. However, previous methods have a limitation in dissecting long-range neural circuits due to inherent limitations on their designs. Moreover, the large size of the previously reported probes induces more significant tissue damage. Herein, we present a multifunctional multi-shank MEMS neural probe that is monolithically integrated with an optical waveguide for optical stimulation, microfluidic channels for drug delivery, and microelectrode arrays for recording neural signals from different regions at the cellular level. In this work, we successfully demonstrated the functionality of our probe by confirming and modulating the functional connectivity between the hippocampal CA3 and CA1 regions in vivo.


Assuntos
Eletrofisiologia/instrumentação , Sistemas Microeletromecânicos , Rede Nervosa/fisiologia , Animais , Região CA1 Hipocampal/citologia , Região CA1 Hipocampal/efeitos dos fármacos , Região CA1 Hipocampal/fisiologia , Região CA3 Hipocampal/citologia , Região CA3 Hipocampal/efeitos dos fármacos , Região CA3 Hipocampal/fisiologia , Sistemas de Liberação de Medicamentos/instrumentação , Masculino , Camundongos , Camundongos Transgênicos , Microeletrodos , Técnicas Analíticas Microfluídicas/instrumentação , Rede Nervosa/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Estimulação Luminosa/instrumentação
13.
Biomed Microdevices ; 21(3): 60, 2019 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-31257546

RESUMO

Minimally invasive delivery of a sustained drug release device to the body is a promising approach for treating chronic conditions such as retinal diseases. Herein, we describe a sheet-type device capable of sustained drug release and deployment control after being applied to the body through a small opened hole via a syringe-type injector. Such device consists of a four-layered structure of thin photopolymerized sheets, which are in turn made of different ratios of a mixture of polyethylene glycol dimethacrylate (PEGDM) and triethylene glycol dimethacrylate (TEGDM). A layer containing a model drug, i.e., fluorescein, was sandwiched between a controlled release and guard layer to achieve sustained unidirectional drug release. A deployment layer was then attached onto the guard layer to control the curvature of the device following deployment. The sheet-type device was sufficiently flexible to be rolled up and could be inserted into a syringe-type injector. When the device was injected into the subconjunctival space of a rabbit eye through a small opened hole, it unfolded to fit the eyeball curvature. Moreover, homogenates of the choroid/retinal pigment epithelium (RPE) as well as the retina exhibited fluorescence during 4 weeks after implantation, confirming that the drug could be delivered to the retina by using the device. This developed sheet-type device offers the possibility of achieving minimally invasive transplantation into diseased tissues and organs, and could provide improved therapeutic modalities as well as reduce possible side effects.


Assuntos
Preparações de Ação Retardada , Sistemas de Liberação de Medicamentos/instrumentação , Animais , Olho/metabolismo , Fluoresceína/metabolismo , Masculino , Coelhos
14.
J Agric Food Chem ; 67(29): 8168-8176, 2019 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-31268318

RESUMO

Protein-based nanoparticles (NPs) with favorable properties including enhanced absorptivity and low toxicity still suffer a major challenge for rapid nutraceutical or drug release after oral administration. Hence, we introduced a secondary encapsulation for unstable factor to attain a controlled-release effect in a gastrointestinal environment. In this work, assembled nanoparticles engineered by nobiletin (NOB), zein, and tannin acid (TA) were first reported for drug delivery systems. The TA added was capable of obtaining further assembly to stabilize nobiletin in comparison with NOB-loaded zein NPs only. Sunflower pollens (SPGs) were selected as carriers for further oral delivery, while zein was chosen as a coating material for capping SPGs absolutely. As a result, the NOB/zein/TA NPs (NZT NPs) obtained had a stable size of 100 nm after 48 h. Besides, they could improve the chemical stability of NOB for at least 120 days at 4 °C compared with zein NPs (ZT NPs). Owing to the secondary capping by SPGs, the final system was able to release selectively via an oral route, that is, achieving no release in a gastric environment and slow release in an intestine environment. Generally, our research proposed a secondary protection model to prevent drug-loaded NPs from resolving after oral administration, which provided a new perspective for nutraceutical or drug encapsulation and controlled-release delivery.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Flavonas/química , Helianthus/química , Pólen/química , Administração Oral , Cápsulas/administração & dosagem , Cápsulas/química , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/química , Portadores de Fármacos/química , Composição de Medicamentos , Sistemas de Liberação de Medicamentos/instrumentação , Flavonas/administração & dosagem , Nanopartículas/química , Tamanho da Partícula , Taninos/química , Zeína/química
15.
J Drugs Dermatol ; 18(7): 663-665, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-31334626

RESUMO

Recalcitrant plantar warts pose a therapeutic challenge. Cidofovir is a viral DNA polymerase inhibitor that has been used in treatment of verrucae with greater success than traditional treatments in some cases. Laser-assisted drug delivery enhances drug penetration beyond the epidermis and is particularly well-suited, though under-utilized, to target palmoplantar verrucae. We report the use of an erbium:yttrium-aluminum-garnet (Er:YAG) ablative fractional laser (AFL) followed by topical cidofovir in treating recalcitrant plantar warts. Two patients were treated with a 2940-nm Er:YAG laser at depths of 1.2-1.5 mm followed by topical application of cidofovir 75 mg/mL. Both patients exhibited a significant reduction in lesion size and improvement in symptoms. AFL-assisted delivery of topical cidofovir represents a promising therapeutic option for recalcitrant plantar warts. J Drugs Dermatol. 2019;18(7):663-665.


Assuntos
Cidofovir/administração & dosagem , Sistemas de Liberação de Medicamentos/instrumentação , Dermatoses do Pé/tratamento farmacológico , Verrugas/tratamento farmacológico , Administração Cutânea , Adulto , Humanos , Lasers de Estado Sólido/uso terapêutico , Masculino , Pessoa de Meia-Idade , Absorção Cutânea/efeitos da radiação , Soluções , Resultado do Tratamento
16.
J Agric Food Chem ; 67(31): 8609-8616, 2019 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-31314514

RESUMO

Quercetin (QUE)-loaded nanoparticles (QCG-NPs) were fabricated by ionic gelation between chitosan (CS) and gum arabic (GA) at pH 3.5. At constant CS (0.5 mg/mL) and QUE (60 µM) concentrations, QCG-NPs (260-490 nm) were prepared uniformly with 0.8-2.2 mg/mL GA and exhibited high QUE encapsulation efficiency (94.8-98.0%) and sustained QUE release (4.42-8.89% after 8 h). Because of the electrostatic interaction between QCG-NPs and the mucin layer, in vitro mucin and cell adhesion of QUE were significantly (p < 0.05) enhanced in QCG-NPs (0.44-0.48 mg/mL and 31.7-78.5%), respectively, and the adhesiveness was significantly (p < 0.05) increased with an increase of GA. Because particle size and adhesion properties affect the surface area and retention time of QCG-NPs at the absorption site, cell permeation of QUE through simple diffusion by QCG-NPs exhibited the same tendency as the adhesion results. These data were verified in cellular antioxidant and in vivo ferric reducing abilities of plasma assays that evaluated the antioxidant activities of QUE absorbed into an intestinal cell model and rat blood, respectively. The results provide a better understanding of QCG-NP absorption and indicate that QCG-NPs with mucoadhesion properties can be an effective delivery system for improving QUE absorption.


Assuntos
Antioxidantes/química , Quitosana/química , Sistemas de Liberação de Medicamentos/métodos , Mucosa Intestinal/metabolismo , Nanopartículas/química , Quercetina/química , Quercetina/metabolismo , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Células CACO-2 , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos/instrumentação , Humanos , Tamanho da Partícula , Quercetina/administração & dosagem , Ratos , Ratos Sprague-Dawley
17.
Food Funct ; 10(8): 4522-4532, 2019 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-31355399

RESUMO

Delivery systems with multicompartmental structures that allow simultaneous delivery of several cargos are of great interest in both fundamental research and industrial applications. Here, we report a facile and easily scalable approach to fabricate multi-compartmentalized microdroplets for achieving programmed release of hydrophobic cargoes. Well-dispersed nanodroplets stabilized by natural Quillaja saponin served as an effective colloid stabilizer for fabricating microscale emulsion droplets with multicompartment architectures comprising many nanoscale droplets as a shell and single microscale core. Control of the number of nanodroplets allows accurate manipulation of the interface permeability for flexible and controllable release of volatile compounds (e.g., 2,3-butanedione, cis-3-hexen-1-ol, ethyl butyrate, d-limonene). More interestingly, the multicompartment microdroplets exhibited a higher flexibility for programmed release of different volatile compounds, as well as curcumin, during in vitro digestion by introducing cargos into the shell subcompartments or core microcompartment. The promising results highlight the power of this multi-compartmentalized system toward accessing a powerful platform for functional cargo delivery strategies.


Assuntos
Curcumina/química , Sistemas de Liberação de Medicamentos/métodos , Extratos Vegetais/química , Quillaja/química , Saponinas/química , Digestão , Sistemas de Liberação de Medicamentos/instrumentação , Emulsões/química , Humanos , Interações Hidrofóbicas e Hidrofílicas , Tamanho da Partícula
18.
Mater Sci Eng C Mater Biol Appl ; 103: 109717, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31349403

RESUMO

In the twenty-first century, microneedles based drug delivery is drawing attention worldwide in the research due to current signs of progress in the controlled release drug delivery through microneedles. The microneedles represent a promising technology to deliver therapeutic compounds into the skin for chronic complications like osteoporosis, diabetes, cancer and induction of immune responses from protein and DNA vaccines. However, the delivery of hydrophilic drugs and macromolecular agents are challenging. In this write up authors included the meticulous illustration of the chronological development of fabrication of microneedles with respect to an assortment of techniques, their modifications, clinical trials and regulatory perspectives period of 2000-2019. This review summarizes characterization, fabrications, biological applications and challenges. Additionally, relevant patents based on microneedle from USPTO) database are also highlighted.


Assuntos
Vacinas Anticâncer/uso terapêutico , Diabetes Mellitus/tratamento farmacológico , Sistemas de Liberação de Medicamentos/métodos , Agulhas , Neoplasias/tratamento farmacológico , Osteoporose/tratamento farmacológico , Vacinas de DNA/uso terapêutico , Sistemas de Liberação de Medicamentos/instrumentação , Humanos , Injeções Intradérmicas/instrumentação , Injeções Intradérmicas/métodos
19.
Drug Metab Rev ; 51(3): 356-377, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31203696

RESUMO

Development of biomedical systems for controllable drug delivery systems and construction of biosensors is imperative to reduce side effects of common treatment techniques and enhance the therapeutic efficacy. To address this issue, metal-organic frameworks (MOFs) as hybrid porous polymeric structures have attracted worldwide attention due to their unprecedented opportunities in vast range of applications in diverse fields including chemistry, biological, and medicinal science as gas storage/separation, sensing, and drug delivery systems. Recently, biomedical application has become an interesting and promising issue for development and usage of multi-functional MOFs. Flexible chemical composition and versatile porous structure of MOFs enable the engineering and enhancement of their medical formulation and functionality as practical carriers for whether therapeutic or imaging agents. One important point in this domain is the efficient delivery of drugs in the body using nontoxic and biodegradable carriers. This review brings together the literatures that addressing the biomedical applications of Zinc-based MOFs (i.e. as drug delivery systems or nontoxic agent in matter of therapeutic applications) to present recent achievements in this interesting field.


Assuntos
Técnicas Biossensoriais/instrumentação , Sistemas de Liberação de Medicamentos/instrumentação , Compostos Organometálicos/química , Zinco/química , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/toxicidade , Biodegradação Ambiental , Humanos , Modelos Moleculares , Compostos Organometálicos/toxicidade , Zinco/toxicidade
20.
Pharm Dev Technol ; 24(9): 1095-1103, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31204552

RESUMO

This study evaluated the delivery efficiency and antitumor effects of the intrapulmonary administration of antitumor small interfering ribonucleic acid (siRNA)-containing nanoparticles to mice with metastatic lung tumor. Fluorescence-labeled, siRNA-containing nanoparticles were administered using Liquid MicroSprayer® to mice with metastatic lung tumors induced by the murine melanoma cell line B16F10. Fluorescent signals in the whole lung and in the tumor region following the intrapulmonary administration of siRNA-containing nanoparticles were stronger than those following intravenous administration. The intrapulmonary administration of nanoparticles containing a mixture of siRNA against MDM2, c-Myc, and vascular endothelial growth factor (VEGF) significantly improved survival and prolonged the survival of mice with metastatic lung tumor. In addition, after the intrapulmonary or intravenous administration of the mixture, the activity levels of interleukin-6 and -12, markers of systemic toxicity, were similar to those of nontreatment. These results indicate that the antitumor siRNA-containing nanoparticles were delivered efficiently and specifically to tumor cells, effectively silencing the oncogenes in the lung metastasis without any significant systemic toxicity.


Assuntos
Sistemas de Liberação de Medicamentos , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Melanoma Experimental/patologia , RNA Interferente Pequeno/administração & dosagem , Animais , Linhagem Celular Tumoral , Sistemas de Liberação de Medicamentos/instrumentação , Feminino , Neoplasias Pulmonares/genética , Camundongos Endogâmicos C57BL , Nanopartículas/química , Proteínas Proto-Oncogênicas c-mdm2/genética , Proteínas Proto-Oncogênicas c-myc/genética , RNA Interferente Pequeno/uso terapêutico , Terapêutica com RNAi/instrumentação , Fator A de Crescimento do Endotélio Vascular/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA